Institute for Research in Operative Medicine, Faculty of Health, School of Medicine, Witten/Herdecke University, Cologne, Germany.
HIV Med. 2013 Nov;14(10):583-95. doi: 10.1111/hiv.12051. Epub 2013 Jun 17.
OBJECTIVES: The objective of this systematic review was to evaluate the effectiveness of adherence-enhancing interventions for highly active antiretroviral therapy (HAART) in HIV-infected patients in developed countries. METHODS: A systematic literature search was performed (January 2001 to May 2012) in EMBASE, including MEDLINE records, CENTRAL and PsycInfo. Trials meeting the following predefined inclusion criteria were included: adult patients with an HIV infection treated with HAART, an intervention to enhance patient adherence, adherence as the outcome, clinical outcomes, randomized controlled trial (RCT), article written in English or German, patient enrolment after 2001, and trial conducted in World Health Organization (WHO) stratum A. Selection was performed by two reviewers independently. All relevant data on patient characteristics, interventions, adherence measures and results were extracted in standardized tables. The methodological trial quality was evaluated by two reviewers independently. All discrepancies were discussed until a consensus was reached. A meta-analysis could not be performed because of the heterogeneity of trials. RESULTS: In total, 21 trials fulfilled all inclusion criteria. Of 21 trials, only one that examined motivational interviewing for alcohol-dependent patients showed statistically significant results for adherence rates and viral load in favour of the intervention. One trial showed a statistically significant clinical effect of the intervention; however, inconsistent results were presented for adherence depending on the underlying adherence definition. The results of the remaining 19 trials were not statistically significant or were conflicting for adherence and/or clinical outcomes. However, the methodological trial quality was low. CONCLUSIONS: It is not possible to definitively assess the effectiveness of adherence-enhancing interventions. However, it appears that most adherence interventions have no effect.
目的:本系统评价旨在评估发达国家中针对接受高效抗逆转录病毒疗法(HAART)的 HIV 感染者的增强药物依从性干预措施的有效性。
方法:对 EMBASE 中的文献(包括 MEDLINE 记录、CENTRAL 和 PsycInfo)进行了系统检索(2001 年 1 月至 2012 年 5 月)。纳入的试验符合以下预先设定的纳入标准:接受 HAART 治疗的 HIV 感染成年患者、增强患者依从性的干预措施、以依从性为结局、临床结局、随机对照试验(RCT)、英文或德文撰写的文章、2001 年后入组的患者以及在世界卫生组织(WHO)A 层开展的试验。由两名评审员独立进行选择。以标准化表格提取患者特征、干预措施、依从性测量和结果的所有相关数据。由两名评审员独立评估试验的方法学质量。所有差异均进行讨论,直至达成共识。由于试验的异质性,无法进行荟萃分析。
结果:共有 21 项试验符合所有纳入标准。在这 21 项试验中,只有一项针对酒精依赖患者的动机性访谈试验显示,在依从率和病毒载量方面,干预措施具有统计学意义上的显著效果。一项试验显示,干预措施具有统计学意义上的临床效果;然而,基于不同的依从性定义,依从性的结果并不一致。其余 19 项试验的结果在依从性和/或临床结局方面均无统计学意义或相互矛盾。但是,试验的方法学质量较低。
结论:目前尚无法明确评估增强药物依从性干预措施的有效性。然而,大多数依从性干预措施似乎没有效果。
Cochrane Database Syst Rev. 2011-12-7
Cochrane Database Syst Rev. 2007-1-24
JBI Database System Rev Implement Rep. 2015-6-12
Cochrane Database Syst Rev. 2010-3-17
Cochrane Database Syst Rev. 2004
Cochrane Database Syst Rev. 2010-11-10
Cochrane Database Syst Rev. 2011-7-6
Cochrane Database Syst Rev. 2007-1-24
Cochrane Database Syst Rev. 2006-7-19
BMC Health Serv Res. 2024-1-10
AIDS Patient Care STDS. 2019-11-21